Eisai Co., Ltd.

Eisai Co., Ltd. is a major pharmaceutical company specializing in the research, development, and manufacture of innovative pharmaceuticals. Its primary function is to deliver prescription drugs and therapies aimed at treating neurological disorders, cancer, and other serious diseases, reflecting its strong commitment to human health and well-being. Eisai operates globally, with a robust presence in both advanced and emerging markets, and employs over 10,000 people dedicated to scientific advancement and quality healthcare provision. The company stands out for significant investments in research and development, particularly targeting areas such as Alzheimer’s disease, oncology, and rare diseases, ensuring it remains at the forefront of medical innovation. As part of the health technology sector, Eisai plays a vital role in shaping therapeutic standards and expanding access to high-impact treatments, while maintaining efficient operations and a solid financial structure marked by strong profitability metrics and consistent sales performance. Through its diversified pharmaceuticals and ongoing pipeline development, Eisai is a pivotal contributor to the evolution of global healthcare solutions.